Editor, Drug Delivery Technology magazine
In the October 2007 issue of Drug Delivery Technology, Dr. David Heyens, vice president of global sales for Catalent, gives an overview of Catalent’s drug delivery technologies and services. He also discusses the key industry trends and issues impacting the pharma and biotech markets for the next five years and explains how Catalent helps companies develop products with improved outcomes and favorable reimbursement status.